University of Texas Medical Branch
Infectious Disease fellowship · Galveston, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is The University of Texas Medical Branch at Galveston's research in infectious disease, which the program shares with other departments and affiliated hospitals.
About The University of Texas Medical Branch at Galvestoninstitution-wide infectious disease research
Infectious Disease publications from The University of Texas Medical Branch at Galveston and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
121
works per year
18th of 71 infectious disease fellowship programs
-20.1%
2-year growth
23rd of 71 infectious disease fellowship programs
35.2%
in top 10% of field (works before 2025)
4th of 67 infectious disease fellowship programs
62.5%
cited above world average
1st of 67 infectious disease fellowship programs
Works per year · * 2026 so far
Infectious Diseases · 589
Infectious Disease research topics at The University of Texas Medical Branch at Galveston
Papers in the window; each links to the list on OpenAlex.
- SARS-CoV-2 and COVID-19 Research 196
- Viral Infections and Vectors 106
- Viral Infections and Outbreaks Research 73
- COVID-19 Clinical Research Studies 59
- Tuberculosis Research and Epidemiology 43
- HIV/AIDS Research and Interventions 30
- Antifungal resistance and susceptibility 14
- Viral gastroenteritis research and epidemiology 13
Most cited at The University of Texas Medical Branch at Galveston since 2024
All infectious disease papers there on OpenAlex
- Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycosesRitesh Agarwal et al. · European Respiratory Journal · 2024 · PubMed · cited 284
- Drug-resistant tuberculosis: a persistent global health concernMaha Reda Farhat et al. · Nature Reviews Microbiology · 2024 · PubMed · cited 262
- Re-emergence of Oropouche virus between 2023 and 2024 in Brazil: an observational epidemiological studyGabriel C Scachetti et al. · The Lancet Infectious Diseases · 2024 · PubMed · cited 166
- A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infectionMohamad‐Gabriel Alameh et al. · Science · 2024 · PubMed · cited 86
- Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicityZemin Yang et al. · Cell Reports · 2024 · PubMed · cited 60
- Structure and inhibition of SARS-CoV-2 spike refolding in membranesMichael W. Grunst et al. · Science · 2024 · PubMed · cited 58
- ICTV Virus Taxonomy Profile: Filoviridae 2024Nadine Biedenkopf et al. · Journal of General Virology · 2024 · PubMed · cited 52
- An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutationsMichael Westberg et al. · Science Translational Medicine · 2024 · PubMed · cited 47
- Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirusRobert W. Cross et al. · Science · 2024 · PubMed · cited 45
- The spatiotemporal ecology of Oropouche virus across Latin America: a multidisciplinary, laboratory-based, modelling studyCarlo Fischer et al. · The Lancet Infectious Diseases · 2025 · PubMed · cited 44